I.-Anne Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
I.-Anne Huang has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Chang-Teng Wu
College of Medicine, Chang Gung University, Taoyuan, Taoyuan, Taiwan
5 shared publicationsTang-Her Jaing
College of Medicine, Chang Gung University, Taoyuan, Taoyuan, Taiwan
5 shared publicationsChao-Ping Yang
3 shared publicationsHsiang-Ju Hsiao
Pediatrics, Chang Gung Memorial Hospital, Keelung, Taiwan
3 shared publicationsJainn-Jim Lin
Department of Pediatrics, Chang Gung Memorial Hospital at Linkou, College of Medicine, Chang Gung University, Taoyuan, Taiwan
3 shared publicationsShao-Hsuan Hsia
Department of Pediatrics, Chang Gung Memorial Hospital at Linkou, College of Medicine, Chang Gung University, Taoyuan, Taiwan
3 shared publications
Latest Publications
- Open Access
Low acuity paediatric emergency visits under single-payer universal health insurance in Taiwan, 2000–2015: a population-based repeated cross-sectional design
Objectives Emergency services utilisation is a critical policy concern. The paediatric population is the main user of emergency department (ED) services, and the main contributor to low acuity (LA) ED visits. We aimed to describe the trends of ED and LA ED visits under a comprehensive, universal health insurance programme in Taiwan, and to explore factors associating with potentially unnecessary ED utilisation. Design and setting We used a population-based, repeated cross-sectional design to analyse the full year of 2000, 2005, 2010 and 2015 National Health Insurance claims data individually for individuals aged 18 years and under. Participants We identified 5 538 197, 4 818 213, 4 401 677 and 3 841 174 children in 2000, 2005, 2010 and 2015, respectively. Primary and secondary outcome measures We adopted a diagnosis grouping system and severity classification system to define LA paediatric ED (PED) visits. Generalised estimating equation was applied to identify factors associated with LA PED visits. Results The annual LA PED visits per 100 paediatric population decreased from 10.32 in 2000 to 9.04 in 2015 (12.40%). Infectious ears, nose and throat, dental and mouth diseases persistently ranked as the top reasons for LA visits (55.31% in 2000 vs 33.94% in 2015). Physical trauma-related LA PED visits increased most rapidly between 2000 and 2015 (0.91–2.56 visits per 100 population). The dose–response patterns were observed between the likelihood of incurring LA PED visit and either child’s age (OR 1.06–1.35 as age groups increase, pConclusion Despite a comprehensive coverage of emergency care and low cost-sharing obligations under a single-payer universal health insurance programme in Taiwan, no significant increase in PED utilisation for LA conditions was observed between 2000 and 2015. Taiwan’s experience may serve as an important reference for countries considering healthcare system reforms.
Open AccessLow acuity paediatric emergency visits under single-payer universal health insurance in Taiwan, 2000–2015: a population-based repeated cross-sectional design
Objectives Emergency services utilisation is a critical policy concern. The paediatric population is the main user of emergency department (ED) services, and the main contributor to low acuity (LA) ED visits. We aimed to describe the trends of ED and LA ED visits under a comprehensive, universal health insurance programme in Taiwan, and to explore factors associating with potentially unnecessary ED utilisation. Design and setting We used a population-based, repeated cross-sectional design to analyse the full year of 2000, 2005, 2010 and 2015 National Health Insurance claims data individually for individuals aged 18 years and under. Participants We identified 5 538 197, 4 818 213, 4 401 677 and 3 841 174 children in 2000, 2005, 2010 and 2015, respectively. Primary and secondary outcome measures We adopted a diagnosis grouping system and severity classification system to define LA paediatric ED (PED) visits. Generalised estimating equation was applied to identify factors associated with LA PED visits. Results The annual LA PED visits per 100 paediatric population decreased from 10.32 in 2000 to 9.04 in 2015 (12.40%). Infectious ears, nose and throat, dental and mouth diseases persistently ranked as the top reasons for LA visits (55.31% in 2000 vs 33.94% in 2015). Physical trauma-related LA PED visits increased most rapidly between 2000 and 2015 (0.91–2.56 visits per 100 population). The dose–response patterns were observed between the likelihood of incurring LA PED visit and either child’s age (OR 1.06–1.35 as age groups increase, pConclusion Despite a comprehensive coverage of emergency care and low cost-sharing obligations under a single-payer universal health insurance programme in Taiwan, no significant increase in PED utilisation for LA conditions was observed between 2000 and 2015. Taiwan’s experience may serve as an important reference for countries considering healthcare system reforms.
- 1 February 2017
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 35 (2) , 379.e1-379.e3
A very rare cause of abdominal pain in a male adolescent: cavernous hemangioma
- 1 February 2017
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 35 (2) , 379.e1-379.e3
A very rare cause of abdominal pain in a male adolescent: cavernous hemangioma
- Open Access
- 1 October 2016
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 57 (5) , 371-377
Comparisons between Full-time and Part-time Pediatric Emergency Physicians in Pediatric Emergency Department
- 1 October 2016
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 57 (5) , 371-377
Open AccessComparisons between Full-time and Part-time Pediatric Emergency Physicians in Pediatric Emergency Department
- Open Access
- 17 July 2015
- Published by Springer Nature in BMC Pediatrics
- Vol. 15 (1) , 85
Clinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit
Invasive pneumococcal disease (IPD) results in high morbidity and mortality globally each year, although it is a vaccine-preventable disease. This study aimed to characterize the clinical features of IPD in a pediatric intensive care unit (PICU) in Taiwan. The seven-valent pneumococcal conjugate vaccine (PCV7) was introduced in the private sector in October 2005. The estimated coverage rate of PCV7 vaccination in 2010 was 45.5 % among children <5 years of age. We conducted a retrospective study at a single center in northern Taiwan for invasive pneumococcal disease in a PICU from 2009 to 2013. Demographic characteristics, clinical courses, serotype, antibiotic susceptibility, and outcomes were analyzed. Over the 5-year study period, 2167 patients were admitted to the PICU; 48 (2.2 %) had IPD. There were 29 female and 19 male patients. Their mean age was 3.7 years (range 0.7–12.5 years, with the peak age at 2–5 years; n = 30, 63 %). Pneumonia was the most frequent type (n = 38, 79 %), followed by meningitis (n = 10, 21 %). In total, three patients died, all within 72 h after admission; the final diagnoses were all meningitis. Thirty-four children with pneumonia received chest tube insertion for pleural effusion drainage. Of them, 22 (65 %) finally still underwent video-assisted thoracoscopic surgery. Eight (17 %) children had hemolytic uremic syndrome, and seven of them underwent hemodialysis. In total, 37 serotypes were detected; 95 % were covered by PCV13. Serotype 19A was most common (54 %) overall; however, in those with meningitis, serotype 19 F was most common. Meningitis is the most severe type of invasive pneumococcal disease in our pediatric intensive care unit. It may progress rapidly even when subjects are given antibiotics promptly. The most common serotype in meningitis is 19 F, which is vaccine preventable. Thus, universal mass pneumococcal vaccination is still needed.
- 17 July 2015
- Published by Springer Nature in BMC Pediatrics
- Vol. 15 (1) , 85
Open AccessClinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit
Invasive pneumococcal disease (IPD) results in high morbidity and mortality globally each year, although it is a vaccine-preventable disease. This study aimed to characterize the clinical features of IPD in a pediatric intensive care unit (PICU) in Taiwan. The seven-valent pneumococcal conjugate vaccine (PCV7) was introduced in the private sector in October 2005. The estimated coverage rate of PCV7 vaccination in 2010 was 45.5 % among children <5 years of age. We conducted a retrospective study at a single center in northern Taiwan for invasive pneumococcal disease in a PICU from 2009 to 2013. Demographic characteristics, clinical courses, serotype, antibiotic susceptibility, and outcomes were analyzed. Over the 5-year study period, 2167 patients were admitted to the PICU; 48 (2.2 %) had IPD. There were 29 female and 19 male patients. Their mean age was 3.7 years (range 0.7–12.5 years, with the peak age at 2–5 years; n = 30, 63 %). Pneumonia was the most frequent type (n = 38, 79 %), followed by meningitis (n = 10, 21 %). In total, three patients died, all within 72 h after admission; the final diagnoses were all meningitis. Thirty-four children with pneumonia received chest tube insertion for pleural effusion drainage. Of them, 22 (65 %) finally still underwent video-assisted thoracoscopic surgery. Eight (17 %) children had hemolytic uremic syndrome, and seven of them underwent hemodialysis. In total, 37 serotypes were detected; 95 % were covered by PCV13. Serotype 19A was most common (54 %) overall; however, in those with meningitis, serotype 19 F was most common. Meningitis is the most severe type of invasive pneumococcal disease in our pediatric intensive care unit. It may progress rapidly even when subjects are given antibiotics promptly. The most common serotype in meningitis is 19 F, which is vaccine preventable. Thus, universal mass pneumococcal vaccination is still needed.
- 1 June 2014
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 55 (3) , 208-212
Headache in the Pediatric Emergency Service: A Medical Center Experience
- 1 June 2014
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 55 (3) , 208-212
Headache in the Pediatric Emergency Service: A Medical Center Experience
- 1 October 2012
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 53 (5) , 304-308
Outcome of Long-Term Mechanical Ventilation Support in Children
- 1 October 2012
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 53 (5) , 304-308
Outcome of Long-Term Mechanical Ventilation Support in Children
- 1 May 2011
- Published by Taylor & Francis in Paediatrics and International Child Health
- Vol. 31 (2) , 159-162
Complicated features in a young child with influenza B virus pneumonia and co-infection withStenotrophomonas maltophilia
A 3.5-year-old child with influenza B virus pneumonia developed pneumomediastinum and subcutaneous emphysema on the 3rd day of illness. Bronchoscopy demonstrated obstruction of the left main bronchus by mucopurulent sputum. Culture of the broncho-alveolar lavage yielded Stenotrophomonas maltophilia. After the respiratory complications resolved (11 days), the patient developed neurological symptoms and was diagnosed as acute disseminated encephalomyelitis (ADEM). Stenotrophomonas maltophilia was probably a factor in the development of pneumomediastinum. To our knowledge, this is the first case report of influenza virus infection with Stenotrophomonas maltophilia co-infection associated with spontaneous pneumomediastinum.
- 1 May 2011
- Published by Taylor & Francis in Paediatrics and International Child Health
- Vol. 31 (2) , 159-162
Complicated features in a young child with influenza B virus pneumonia and co-infection withStenotrophomonas maltophilia
A 3.5-year-old child with influenza B virus pneumonia developed pneumomediastinum and subcutaneous emphysema on the 3rd day of illness. Bronchoscopy demonstrated obstruction of the left main bronchus by mucopurulent sputum. Culture of the broncho-alveolar lavage yielded Stenotrophomonas maltophilia. After the respiratory complications resolved (11 days), the patient developed neurological symptoms and was diagnosed as acute disseminated encephalomyelitis (ADEM). Stenotrophomonas maltophilia was probably a factor in the development of pneumomediastinum. To our knowledge, this is the first case report of influenza virus infection with Stenotrophomonas maltophilia co-infection associated with spontaneous pneumomediastinum.
- 1 January 2011
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 33 (1) , 18-21
Cord Blood Transplantation in Children With Relapsed or Refractory Severe Aplastic Anemia
Early results of cord blood transplantation (CBT) for severe aplastic anemia were poor with a high rate of engraftment failure. We carried out CBT in 5 children with relapsed or refractory severe aplastic anemia, using immunosuppressive preparative regimens. The median time from the diagnosis to the CBT was 16 months (15 to 47 mo), with all the children having failed at least 1 course of immunosuppressive therapy. The conditioning regimens consisted of fludarabine, cyclophosphamide, and antithymocyte globulin. One patient had an HLA-identical sibling donor, and 4 had unrelated donors selected from an NMDP-affiliated cord blood bank. Two patients received double-unit grafts to attain a target TNC dose of at least 3.0×10/kg. Donor/recipient HLA matching was 6 of 6 (n=2) and 5 of 6 (n=5). The median nucleated cell dose infused was 5.6 (range, 3.6 to 6.1) ×10 cells/kg. The median infused CD34 dose was 2.9 (range, 1.8 to 7.5) ×10 cells/kg. All the patients achieved neutrophil engraftment at a median of 13 days (range, 11 to 25 d). The median time to platelet engraftment was 48 days (range, 34 to 56 d). After CBT, acute GVHD developed in 4 cases, CMV reactivation in 1, pneumonia in 1, and sepsis in 1. Four patients successfully engrafted, but 1 failed to engraft and had delayed autologous recovery. However, all patients were now transfusion-independent at the time of reporting. This result suggests that CBT using optimal conditioning regimens can be a salvage treatment for patients without a suitable bone marrow donor and warrants further prospective studies.
- 1 January 2011
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 33 (1) , 18-21
Cord Blood Transplantation in Children With Relapsed or Refractory Severe Aplastic Anemia
Early results of cord blood transplantation (CBT) for severe aplastic anemia were poor with a high rate of engraftment failure. We carried out CBT in 5 children with relapsed or refractory severe aplastic anemia, using immunosuppressive preparative regimens. The median time from the diagnosis to the CBT was 16 months (15 to 47 mo), with all the children having failed at least 1 course of immunosuppressive therapy. The conditioning regimens consisted of fludarabine, cyclophosphamide, and antithymocyte globulin. One patient had an HLA-identical sibling donor, and 4 had unrelated donors selected from an NMDP-affiliated cord blood bank. Two patients received double-unit grafts to attain a target TNC dose of at least 3.0×10/kg. Donor/recipient HLA matching was 6 of 6 (n=2) and 5 of 6 (n=5). The median nucleated cell dose infused was 5.6 (range, 3.6 to 6.1) ×10 cells/kg. The median infused CD34 dose was 2.9 (range, 1.8 to 7.5) ×10 cells/kg. All the patients achieved neutrophil engraftment at a median of 13 days (range, 11 to 25 d). The median time to platelet engraftment was 48 days (range, 34 to 56 d). After CBT, acute GVHD developed in 4 cases, CMV reactivation in 1, pneumonia in 1, and sepsis in 1. Four patients successfully engrafted, but 1 failed to engraft and had delayed autologous recovery. However, all patients were now transfusion-independent at the time of reporting. This result suggests that CBT using optimal conditioning regimens can be a salvage treatment for patients without a suitable bone marrow donor and warrants further prospective studies.
- 1 July 2010
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 28 (6) , 749.e1-749.e3
Guillain-Barré syndrome presenting as mimicking croup
- 1 July 2010
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 28 (6) , 749.e1-749.e3
Guillain-Barré syndrome presenting as mimicking croup
- 1 January 2009
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 26 (7) , 487-495
SINGLE-CENTER EXPERIENCE: Immunosuppressive Therapy as Frontline Treatment for 33 Children with Acquired Severe Aplastic Anemia
The authors retrospectively analyzed the records of 33 children with acquired severe aplastic anemia (SAA) diagnosed from July 1998 to October 2007 and first treated by immunosuppressive therapy (IST). Serial hematologic parameters, complications, transfusion requirements, and time to response were assessed. Allogeneic hematopoietic stem cell transplantation (HSCT) was attempted in 7 patients after failure of IST (n = 6) or relapse following an initial response to IST (n = 1). One child died of post-transplant lymphoproliferative disorder. Thirty of the 33 patients are alive and well after a median follow-up of 45 months (range, 7–116 months). Overall (transfusion-independent) response to IST was 73% (24/33). The actuarial 5 years survival rate was 89.4%. In this study, all patients with SAA received IST as standard front-line therapy. Approximately three-fourths of patients with SAA have durable recovery and excellent overall survival.
- 1 January 2009
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 26 (7) , 487-495
SINGLE-CENTER EXPERIENCE: Immunosuppressive Therapy as Frontline Treatment for 33 Children with Acquired Severe Aplastic Anemia
The authors retrospectively analyzed the records of 33 children with acquired severe aplastic anemia (SAA) diagnosed from July 1998 to October 2007 and first treated by immunosuppressive therapy (IST). Serial hematologic parameters, complications, transfusion requirements, and time to response were assessed. Allogeneic hematopoietic stem cell transplantation (HSCT) was attempted in 7 patients after failure of IST (n = 6) or relapse following an initial response to IST (n = 1). One child died of post-transplant lymphoproliferative disorder. Thirty of the 33 patients are alive and well after a median follow-up of 45 months (range, 7–116 months). Overall (transfusion-independent) response to IST was 73% (24/33). The actuarial 5 years survival rate was 89.4%. In this study, all patients with SAA received IST as standard front-line therapy. Approximately three-fourths of patients with SAA have durable recovery and excellent overall survival.